Abstract-Pharmaceuticals have a wide range of biological properties and are released into the environment in relatively large amounts, yet little information is available regarding their effects or potential ecological risks. We exposed outdoor aquatic microcosms to combinations of ibuprofen (a nonsteroidal anti-inflammatory drug), fluoxetine (a selective serotonin reuptake inhibitor), and ciprofloxacin (a DNA gyrase-inhibiting antibiotic) at concentrations of 6, 10, and 10 g/L, respectively (low treatment [LT]); 60, 100, and 100 g/L, respectively (medium treatment [MT]); and 600, 1,000, and 1,000 g/L, respectively (high treatment [HT]). We maintained these concentrations for 35 d. Few responses were observed in the LT; however, effects were observed in the MT and HT. Fish mortality occurred in the MT (Ͻ35 d) and in the HT (Ͻ4 d). Phytoplankton increased in abundance and decreased in diversity (number of taxa) in the HT, with consistent trends being observed in the MT and LT. Zooplankton also showed increased abundance and decreases in diversity in the HT, with consistent trends being observed in the MT. Multivariate analyses for zooplankton and phytoplankton suggested interactions between these communities. Lemna gibba and Myriophyllum spp. showed mortality in the HT; growth of L. gibba was also reduced in the MT. Bacterial abundance did not change in the HT. All responses were observed at concentrations well below the equivalent pharmacologically active concentrations in mammals. Although the present data do not suggest that ibuprofen, fluoxetine, and ciprofloxacin are individually causing adverse effects in surface-water environments, questions remain about additive responses from mixtures.
INTRODUCTION
Pharmaceuticals and pesticides are estimated to be discharged into surface water at similar rates [1] . Pharmaceuticals, however, are commonly released into surface waters yearround and wherever humans reside, whereas pesticides are not. Pharmaceuticals enter surface waters via sewage treatment plant effluent as well as untreated human and livestock sewage; in addition, large volumes of untreated sewage enter the U.S. and Canadian surface water daily. The U.S. Geological Survey recently analyzed U.S. surface water for 40 pharmaceuticals and found 28 at detectable concentrations [2] . The authors of the survey did not speculate regarding the ecological significance of these detections, but they did cite the need for effects data.
Despite the volume of daily releases into surface water, the effects of pharmaceuticals on the aquatic ecosystem and its organisms are largely unknown [1, [3] [4] [5] [6] . The limited data regarding environmental effects of pharmaceuticals consists of single-species, acute laboratory bioassays [7] [8] [9] . Given the wide range of pharmaceuticals and their numerous modes of action, many concerns remain about organisms inhabiting surface water receiving sewage.
To address these concerns, we conducted a pilot-study using model, outdoor aquatic ecosystems (microcosms) containing bacteria, plankton, plants, and fish. Because pharmaceuticals are continuously released at low concentrations into the environment and likely are present as complex mixtures, it was judged to be more relevant to perform chronic tests with mixtures of compounds. Chronic tests encompass the life cycles of nontarget organisms and can identify sensitive stages of development and subtle responses. Furthermore, tests with outdoor aquatic microcosms enable the evaluation of stressor responses by organisms from different trophic levels [10] and, thus, are better able to reveal direct and indirect effects on complex aquatic communities under realistic environmental conditions [11] . By chronically exposing aquatic organisms in microcosms, effects on a large number of species as well as those caused by food-web interactions over multiple trophic levels can be examined simultaneously. Important ecological factors, such as resiliency, redundancy, and recovery, that may mitigate the impact of toxicants in surface waters can also be observed in tests with microcosms.
MATERIALS AND METHODS
All experiments were conducted at the Centre for Toxicology, Microcosm Research Facility, located at the Guelph Turf-Grass Institute at the University of Guelph (Guelph, ON, Canada). Each microcosm had a surface area of 11.95 m 2 , a depth of 1.05 m, and a total volume of 12,000 L. Each microcosm was lined with black, food-grade polyvinyl chloride. An irrigation pond (length ϫ width ϫ depth, 62 ϫ 62 ϫ 4 m) adjacent to the microcosms was filled from a deep (130-m) well. This irrigation pond was the water source for all microcosms.
The objective of using microcosms was to create model aquatic ecosystems. To establish aquatic communities, an amended sediment (Evergreen Sod, Waterdown, ON, Canada) was added to plastic propagating trays (52 ϫ 25 ϫ 7 cm; Plant Products, Brampton, ON, Canada). The sediment consisted of a 1:1:1 mixture of sand, loam, and organic matter (mainly composted manure) by volume and was hand-sifted through a screen with a 12-mm mesh. Forty-five sediment trays, filled to a depth of 5 cm, were placed evenly across each microcosm floor, resulting in a total aerial coverage of 55%. The microcosms were circulated for two weeks (one turnover per day) by pumping water between the irrigation pond and each microcosm. This circulation ensured uniform development of periphyton, phytoplankton, zooplankton, algae, and benthic communities and also promoted homogeneity both between and among microcosms.
Assessing the effect of commonly prescribed pharmaceutical mixtures on aquatic communities in microcosms was the objective of the present study. Therefore, pharmaceuticals were selected based on mode of action and frequency of prescription in North America (www.rxlist.com). Because of the volume needed to maintain the desired exposure concentrations, availability of large quantities (1 kg) was also a condition of selection. Ibuprofen, fluoxetine, and ciprofloxacin met the established criteria. These three compounds were used in an eight-microcosm pilot study. Across these eight microcosms, three dilutions of a three-pharmaceutical mixture were used in a concentration-response design. Because of limited availability of microcosms, we felt that the best way to characterize effects was to assign triplicate microcosms to the highest treatment and control as well as single microcosms to the low and medium treatments. This resulted in three control and five treated microcosms receiving a ternary mixture of ibuprofen, ciprofloxacin, and fluoxetine at three concentrations for 35 d (Table 1) . The five treated microcosms were designated as high treatment (HT; n ϭ 3), medium treatment (MT; n ϭ 1), and low treatment (LT; n ϭ 1). Treatment concentrations for ibuprofen were chosen based on distributional analyses of upper exposure centiles (e.g., 95th, 99th, and 99.9th) estimated from actual surface-water concentrations [6, 12, 13] . At the time of the present experiment, surface-water concentrations of ciprofloxacin and fluoxetine were not available; therefore, exposure concentrations of these two compounds were based on upper centile distributions of other pharmaceuticals found in surface water [1] . To maintain constant concentrations of pharmaceuticals, as would be expected in surface water receiving sewage treatment plant effluent, concentrations in the microcosms were quantified at intervals of 2 d and subsequently treated again to maintain nominal concentrations as the residue analyses dictated. This resulted in 48-h, time-weighted average concentrations within 10% of nominal values. Biological samples (phytoplankton, zooplankton, macrophytes, and bacteria) were collected 1 d before pharmaceutical treatment (-1 d) and at 4, 7, 14, 21, 28, and 35 d after the initial treatment; fish were observed daily.
By exposing the aquatic microcosms to the 95th, 99th, and 99.9th centile concentration of pharmaceuticals found in surface water, the present study examines a worst-case scenario. Our exposure concentrations exceed that of individual pharmaceuticals normally found in the environment; however, we wanted to account for the possibility of additivity among compounds with the same mode of action and to provide a highexposure scenario for future probabilistic risk assessments.
Chemicals
Ibuprofen (98.0% purity) was supplied by Sigma-Aldrich (Oakville, ON, Canada). Ciprofloxacin (98.0% purity) and fluoxetine (99.9% purity) were supplied by Interchem (Paramus, NJ, USA). Triethylamine (Ͼ99%), N,N-dimethylformamide (99.8%), sodium monophosphate (Ͼ99%), and potassium monophosphate (Ͼ99%) were purchased from ACP (Montreal, PQ, Canada); o-phosphoric acid (Ͼ85%) was obtained from Bund Deutscher Heilpraktiker (Toronto, ON, Canada). Highperformance liquid chromatographic (HPLC) grade acetonitrile (Ͼ99%) was purchased from Fisher (Toronto, ON, Canada). Barnstead E-pure water (Dubuque, IA, USA) with a resistance of 18 M⍀ cm Ϫ1 was used.
Fish
Juvenile sunfish (Lepomis gibbosus) were enclosed in mesh cages (diameter ϫ length, 35.5 ϫ 60 cm) and exposed to the pharmaceutical mixture for 35 d. Each microcosm contained a total of 30 fish evenly divided between two mesh cages. The total area of the microcosm that the sunfish occupied equaled 1% of the volume of the microcosms. Fish were monitored daily for mortality. Naturally occurring plankton were the primary food source; no external food was added to the cages or microcosm. However, because of the small volume occupied by the fish, the passive feeding, and the results from previous studies in these microcosms, we maintain that fish do not significantly reduce plankton populations (K. Solomon et al., unpublished data).
Phytoplankton collection and enumeration
Phytoplankton were collected from 2-L integrated samples. A 250-ml aliquot was removed and preserved with Lugol's solution. Taxonomic identification of phytoplankton was conducted by Aquatic Analysts (Middleville, NJ, USA). The numbers determined from these assessments were used to calculate an abundance value for 1-ml subsamples (n ϭ 3). Subsample values were then averaged and expressed as the number per liter of water. Organisms were identified to the lowest taxonomic level (usually species) based on a variety of keys.
Zooplankton collection and enumeration
Zooplankton samples were collected using activity traps modeled after those of Whiteside and Williams [14] . Eighteen hours before a sampling event, duplicate traps, consisting of three funnels each (area of funnel opening, 170 cm 2 ), were filled with filtered pond water and suspended horizontally midway in the water column of each microcosm. The samples were collected by pulling the traps to the surface in a horizontal position and quickly turning the trap upright to prevent sample loss. Both traps from each pond were combined and filtered
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Environ. Toxicol. Chem. 23, 2004 1037 through a 30-m mesh (Nitex; Dynamic Aqua Supply, Surrey, BC, Canada). Zooplankton were washed into a 125-ml glass bottle, narcotized with 16% soda water, and preserved with 10 ml of sugar formalin (37% formaldehyde). Processing of the zooplankton samples for taxonomic identification was conducted in-house on triplicate 1-ml aliquots (subsamples) transferred to a Sedgwick-Rafter chamber (Ward's Natural Science, St. Catherine's, ON, Canada). These subsamples were individually enumerated with a minimum of 100 organisms counted along three transects of the SedgwickRafter chamber. These counts were used to calculate abundance values, which were later used in principal response curves (PRCs). All organisms were identified to the lowest possible taxonomic unit [15] [16] [17] .
Analysis of plankton community responses
Treatment-dependent changes in the structure and recovery of the phytoplankton and zooplankton community were analyzed using PRCs. This method of multivariate analysis summarizes information regarding all populations simultaneously, thereby providing a unique method to elucidate the effects of pharmaceuticals at the community level. The objective is to reveal comprehensive patterns contained within the data. The PRCs are derived from redundancy analysis, which has been shown to be an effective statistical approach for assessing response-recovery relationships in stressed aquatic communities, based on species abundance data [18, 19] . Redundancy analysis compares response patterns between treatments and controls by plotting time-treatment trajectory lines in ordination space. Redundancy analysis, however, is not able to show how treatment effects develop over time or how effects depend on the treatment level [19] . The PRC improves on this by using the control trajectory over time as a reference for all other treatment trajectories. Control is plotted as a horizontal reference line, with time being defined as the horizontal axis, and the treatment trajectories are re-expressed relative to the control line. The result is a PRC for each treatment, describing the chief response of the community over the course of the experiment, in terms of changes in abundance of the species studied [18] .
The model used to derive the PRC was y b(i)tk ϭ y 0tk ϩ b k h bt ϩ ⑀ b(i)tk . The variables (as described by Van den Brink and Ter Braak [20] ) are as follows: y b(i)tk is the abundance count of taxon k at time t in replicate i of treatment b, y 0tk is the mean abundance in controls (0) for each sampling date, h bt is the principal response of treatment b at time t (PRC graph coordinates), b k is the weight of species k with respect to [h bt ], and ⑀ b(i)tk is the error term.
To determine the relative contribution of each species to the community response as described by a PRC, a speciesweight plot is generated (see Figs. 1 and 2) , based on the mathematical model above. Species with high, positive weights conform to the principal response pattern indicated by the PRCs, whereas those with negative weights exhibit the opposite pattern. Species with weights approaching zero do not conform to either pattern. Weight is the same for a given species at all treatment levels, because it is also partly a value describing a set relation between species in the study. The relative contribution of a single species to the principal responses, compared to the other species studied, stays the same, whereas weights are unique to each data set/study. To assess the statistical significance of treatment-related differences between PRCs, a Monte Carlo permutation analysis (n ϭ 999 permutations, ␣ ϭ 0.05) [21] was conducted using CANOCO (Ver 4.0) [22] .
In the present study, PRCs were used to measure the response of the plankton communities, but they were not used to measure the response of macrophytes or fish. The plankton communities were much more complex and dynamic than our populations of plants and fish and, therefore, required a different statistical approach. The PRC analysis is ideally suited for measuring multispecies and community responses and, thus, is the tool of choice for the analysis of plankton response described herein. The bacterial community would also have been well suited for PRC analysis, if identified to a uniform taxonomic unit. As for the plants and fish, instead of a PRC and Monte Carlo permutation test, a Dunnett's test (␣ ϭ 0.05) was used to determine statistical differences between HT and control parameters.
Aquatic plants
Myriophyllum spicatum and M. sibiricum were initially cultured in the laboratory according to standard methods [23] and transferred to the microcosms according to the methods of Hanson et al. [24] . Plants were sampled 1 d before pharmaceutical exposure and at 4, 7, 14, 21, 28, and 35 d after pharmaceutical exposure. Somatic endpoints measured included growth (plant length), biomass (wet mass), root number (primary roots from the plant stem), primary root lengths (total and longest), and number of nodes. Myriophyllum spp. were not tested at the LT and MT concentrations because of an unforeseen shortage of laboratory cultures.
Duckweed, Lemna gibba L., was cultured in the laboratory and then transferred to the microcosm according to established methods [25] , except that 10 g/L of sucrose were used instead of 30 g/L in the growth media to ensure that all plants were at a consistent stage of development before exposure. The L. gibba was introduced into the microcosms immediately after pharmaceutical treatment (day 0) for a 35-d exposure duration and was maintained as previously described [24] . Growth [26] was used as a measure of effect and was modeled by
The growth rate (k) [26, 27] for fronds was calculated as
where t is the duration of the test in days, F 0 is the initial number of fronds or plants, and F t is the number of fronds or plants at the end of the test.
Bacterial abundances
Formalin-fixed samples of 10 to 20 ml were filtered onto black membrane filters (pore size, 0.22 mm; diameter, 25 mm; Osmonic, Minnetonka, MN, USA) and stained with a final concentration of 2 mg/ml of 4Ј,6Ј-di-amidino-2-phenylindole. Bacterial abundances were determined by epifluorescence microscopy as previously described [28] .
Analytical methods
Pharmaceutical concentrations in the microcosms were quantified via HPLC analyses performed using a Waters 600 chromatograph (Milford, MA, USA) and pump connected to a Waters 486 variable-wavelength detector. Ultraviolet-visible absorption spectra were recorded using a Hewlett-Packard 8452A diode array spectrophotometer (Avondale, PA, USA). The HT and MT pond-water samples were not filtered before analysis. Injection volumes ranging from 20 to 100 l were made in duplicate by a Waters 717 autosampler. Isocratic separations were performed at room temperature using a reversephase Alltima C-18 column (5 m, 250 ϫ 4.6 mm; Alltech, Deerfield, IL, USA) preceded by an Alltech C-18 guard cartridge. Separation of ibuprofen and fluoxetine was achieved using a mobile-phase consisting of 55% acetonitrile:45% buffer (0.01 M KH 2 PO 4 /0.14% triethylamine/0.2% o-phosphoric acid); for ciprofloxacin analysis, the mobile-phase composition was 10% acetonitrile:90% buffer (0.01 M NaH 2 PO 4 /6% N,Ndimethylformamide/0.5% triethylamine/0.02% o-phosphoric acid). All solvents and buffers were filtered before use. A flow rate of 1 ml/min was used for all analyses. Detection was performed at 274 nm for ciprofloxacin and at 230 nm for ibuprofen and fluoxetine, and quantitation was based on external calibration where the linearity ranges for ciprofloxacin, fluoxetine, and ibuprofen were 0.02 to 30.0 mg/L, 4.0 nl/L to 40.0 mg/L, and 0.02 to 14.0 mg/L, respectively. The limit of detection of the three pharmaceuticals using the analytical method described above was between 3.0 and 15.0 mg/L. The relative standard deviation for replicate analyses was less than 10%.
RESULTS AND DISCUSSION
Our findings show that organisms at multiple trophic levels were affected by the HT and MT concentrations ( Table 2) . Because of the sample size (n ϭ 1), we were not able to test the statistical significance of any differences observed in the MT or LT.
Fish
Treatment-dependent lethality was observed in sunfish. Within the first 96 h of HT exposure, all sunfish died (n ϭ 90). The trial was repeated on day 8; within 4 d, 98.8% of these fish died. After 35 d of exposure in the MT microcosm, 46.7% of sunfish had died (n ϭ 14/30). During the same period, 1.1% of controls died (n ϭ 1/90), and no LT fish (n ϭ 30) died.
The mechanisms of toxicity in the fish are unclear. The treatments administered were not expected to induce mortality, because MT concentrations were more than 230-, 130-, and 11-fold lower than those equivalent to mammalian whole-body therapeutic doses for ibuprofen, ciprofloxacin, and fluoxetine, respectively. These ratios were calculated by first assuming a complete equilibrium of the pharmaceuticals between the fish and the water and then comparing the value to the therapeutic dose in humans. For example, in the MT fish, ciprofloxacin was equivalent to 0.1 mg/kg. At the corresponding therapeutic dose per 24 h of 800 mg per 60-kg person, the resulting value is 130.3 mg/kg [29] .
One plausible hypothesis for the mechanism of toxicity to the fish is that fluoxetine exposure led to increased plasma serotonin levels. Serotonin constricts the arterio-arterial branchial vasculature, leading to impaired gas exchange and hypoxia, ultimately leading to death [30] . Other potential factors S.M. Richards et al. that could affect lethality (e.g., dissolved oxygen and pH) were not significantly different between treatments. Synergistic interactions, wherein the combination of the three drugs may have increased the potency of one or all, also may account for the toxicity observed in the sunfish; however, this remains to be tested.
Phytoplankton
The phytoplankton community PRC showed a significant (p ϭ 0.012) treatment-related response characterized by a decrease and subsequent resurgence in many of the species for HT and MT microcosms (Fig. 1) . By 7 d of exposure, the HT and MT populations decreased dramatically. Partial recovery occurred by 21 d, yet the HT populations, as indicated by the time-response trajectory, remained reduced compared to control after 35 d of exposure (Fig. 1) .
Differences between the abundance and diversity (number of taxa) of controls and HT phytoplankton populations over time were compared using Student's t test (␣ ϭ 0.05) (Fig.  1c) . Abundance increased significantly by 7 d of exposure (p ϭ 0.007) through 35 d, with the exception of day 21. Phytoplankton diversity decreased significantly at 21 d (p ϭ 0.002) and both subsequent time points (28 d, p ϭ 0.013; 35 d, p ϭ 0.003). There appears to be a discrepancy between the PRC (Fig. 1a) of the phytoplankton when compared to the corresponding abundance raw data (Fig. 1c) . This ostensible discrepancy is the result of one species, Synechocystis aquatilis. This species was significantly increased in abundance, but in general, the rest of the phytoplankton community did not increase. This one species of phytoplankton, however, increased to such an extent that the total abundance was increased relative to control and caused a loss of statistical resolution for the less common species. Thus, the raw total abundance data are skewed by the dramatic increase of just one species. The more refined view of PRC is an amalgamation of all populations and indicates a decrease. Because of a limited sample size, statistical analysis was not possible with the LT and MT responses; however, the responses indicate the same treatmentdependent increase in abundance and decrease in diversity over time. In summary, the phytoplankton community was characterized by a treatment-dependent decline and late resilience to the pharmaceutical mixture.
Zooplankton
The response of zooplankton species composition over time was analyzed using PRC, as described above (Fig. 2a) . The zooplankton PRC demonstrated a significant (p ϭ 0.010, Monte Carlo permutations, n ϭ 999), concentration-dependent response of the zooplankton community to the pharmaceutical mixture. Zooplankton community abundance increased up to 14 d in the HT, after which little change in response was observed. The accompanying species weight line (Fig. 2b) shows that Cladocera (Chydorus spp.) contributed to the main trend of the PRC, as indicated by their positive species weight. This type of response implies dominance in the community. Rotifers (e.g., Keratella cochlearis), however, did not contribute to the main trend of the PRC. Rather, the rotifers exhibited a pattern opposite to the PRC, as indicated by the their negative species weight, meaning in this case a reduction and eventual disappearance from the community. The PRC of the zooplankton in the MT and LT microcosms also indicates a treatment-dependent increase in zooplankton abundance over time.
Significant increases in zooplankton abundance occurred at 21 d (p Ͻ 0.001) and remained elevated until the end of the treatment (Fig. 2c and d) . Decreases in zooplankton diversity (number of taxa) occurred soon after exposure (day 4, p ϭ 0.001) and at every subsequent observation time, with the exception of day 21, which was not significant (p ϭ 0.055). As with the phytoplankton, LT and MT zooplankton showed dose-dependent, proportional deviations in abundance and diversity.
A decrease in diversity in both zooplankton and phytoplankton communities may have important ecological implications. Community stability and productivity have been positively correlated with species diversity [31, 32] . Ecological diversity and redundancy within trophic levels are important components of community resiliency in the face of anthropogenic perturbation [33, 34] . Determining which species have a significant role in community function, however, remains an open empirical question [32] . The cause of the decline in diversity of the plankton communities is also uncertain; the ternary mixture could have directly or indirectly affected either or both plankton communities. Direct effects would be caused by an inherent toxicity of the mixture or its metabolites, which
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Plants
The MT and HT mixtures were toxic to L. gibba (duckweed) and Myriophyllum spp. At 7 d, L. gibba growth rates [27] were 0.246, 0.248, 0.122, and Ϫ0.078 per day in the control, LT, MT, and HT microcosms, respectively. Dying and dead plants were indicated mathematically by a reduced and a negative growth rate, respectively. Plant death occurred after 7 d of HT exposure. By 14 d, all plants in the HT were dead, and MT plants began to die (MT k ϭ Ϫ0.143 per day). Sublethal effects (chlorosis and necrosis) were associated with decreased growth rates in the MT and HT. No decreases in growth rate or sublethal effects occurred through 35 d of control or LT exposure. Myriophyllum spicatum and M. sibricum were similarly affected; total length, root growth, and the number of nodes were reduced relative to control by 88%, 84%, and 64%, respectively, in the HT.
The phytotoxicity exhibited by the MT and HT mixtures is consistent with laboratory tests on ciprofloxacin and plants [35] . Fluoroquinolones hinder bacterial DNA synthesis by inhibiting bacterial topoisomerase II and topoisomerase IV [36, 37] . Ultimately, this interferes with normal transcription and replication. Ciprofloxacin's mechanism of phytotoxicity may result from a similar inhibitory effect on chloroplast DNA, which is homologous to bacterial DNA [37] .
Bacteria
After 35 d of exposure, no significant difference (p Ͼ 0.05) in total abundance between treatments was detected. Bacterial abundance estimates, as performed here, treat the bacterial community as a homogeneous assemblage of cells, which does not consider the high diversity of phylogenetic types that are present. Changes in community composition may not have been detectable in the estimates of abundance but are ecologically important. Until these parameters are known, it will be difficult to conclude that the ternary mixture did not affect bacteria. For example, in the present study, zooplankton abundance was not affected until after changes in diversity were detected.
CONCLUSION
A mixture of pharmaceuticals applied to aquatic microcosms affected organisms at multiple trophic levels. The fish mortality, macrophyte mortality, increased abundance, reduced diversity, and community-level effects among plankton populations observed in the present study raise questions about the potential for similar effects in surface waters.
The exact reasons for the effects noted in the present study are not known. Throughout the course of the 35-d trial, significant amounts of organic pharmaceuticals were added to each treatment microcosm. Therefore, not only does the physiological effect of the pharmaceuticals need to be addressed, so does the effect of adding organic matter. It is possible that this organic enrichment could have contributed to some of the effects observed in the present study; however, bacterial abundance, perhaps the most sensitive indicator of organic enrichment, did not increase. If organic enrichment did contribute to the observed effects, it does not negate the effect or need for concern, because sewage containing pharmaceuticals would have higher organic content. Another confounding factor in concluding that pharmaceuticals were solely responsible for the effects seen in the present study is the absence or reduced abundance of fish in the HT and MT microcosms. Although the fish in the control microcosms occupied a very small, fixed volume (1% v/v), the potential effects of their passive grazing on the zooplankton and phytoplankton should be noted. If enough of the plankton population cycled or migrated through the fish cage, a reduced diversity in the zooplankton and/or phytoplankton could occur. By reducing the diversity, plankton that were previously suppressed may flourish, thus increasing the overall plankton biomass. However, fish abundance in the LT was not significantly decreased, yet the LT PRC trend followed those of the HT and MT microcosms. Regardless of the reason or whether the effects were directly or indirectly caused, significant differences occurred in flora and fauna of microcosms treated with pharmaceuticals.
Based on recent U.S. Geological Survey data [2] and the results in the present study, a low probability exists that ibuprofen, ciprofloxacin, and fluoxetine are currently present in surface water at concentrations great enough to affect aquatic communities. The greatest concentrations of ibuprofen, fluoxetine, and ciprofloxacin detected by the U.S. Geological Survey were 1.0, 0.012, and 0.03 g/L, respectively [2] . Indeed, we do not believe that the three pharmaceuticals examined in the present study are individually affecting environmental surface-water communities at currently measured concentrations; however, data regarding concentrations of pharmaceuticals in surface water are incomplete. In typical surface waters receiving sewage effluent, many pharmaceuticals could be present [2] . In the United Kingdom and Canada alone, more than 3,000 pharmaceuticals are licensed for use [38, 39] , but few of these have been searched for in surface water. Many of these 3,000 pharmaceuticals share the same mode of action in mammals and could act additively in other organisms. For example, in their review of pharmaceuticals in the environment, Daughton and Ternes [1] discuss 50 pharmaceuticals of concern. Of these, 16 are analgesics, and three are selective serotonin reuptake inhibitors. The fluoroquinolones are described simply as a large class. Consequently, when surface-water concentrations of pharmaceuticals sharing a common mechanism of action are further elucidated, the effective (additive) environmental concentrations may be more substantial [1] and closer to concentrations that were associated with effects in the present study.
In the present study, we examined only three pharmaceuticals, each with a unique mode of action and at one mixture ratio. The effects of many more pharmaceuticals in other combinations should be studied. Although we detected responses in many zooplankton and phytoplankton species, we examined only one vertebrate species and two aquatic macrophyte species. Other species in these groups may be more or less susceptible. The specific mechanisms of toxicity are unclear; however, because of the temporal distribution of observed effects across trophic levels and taxa, multiple mechanisms of action likely are involved.
Our results strongly suggest that a more definitive assess-ment of risks posed by mixtures of pharmaceuticals in surface waters should be conducted. As additional toxicity data for other species become available, mechanisms of action elucidated, homologies of sensitivity identified, and environmental concentrations more widely characterized, species-sensitivity distributions can be constructed and used with probabilistic risk assessment to distinguish high-risk combinations of exposures and sensitive species [40] . This information can be used to place these risks in an ecosystem context, to identify needs for improved treatment processes, and to quantify thresholds above which mitigation would be needed.
